The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1486-1496

  Fraczek, Marcin G ^a,b   Bromley, Michael ^a,b   Buied, Ahmed ^a,b   Moore, Caroline B ^a,b   Rajendran, Ranjith ^c   Rautemaa, Riina ^a,b   Ramage, Gordon ^c   Denning, David W ^a,b   Bowyer, Paul ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antifungal; Aspergillosis; Azole resistance; Drug resistance; Efflux pumps

Indexed keywords

CDR1B PROTEIN; ITRACONAZOLE; MULTIDRUG RESISTANCE PROTEIN; STEROL 14ALPHA DEMETHYLASE; UNCLASSIFIED DRUG;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOINFORMATICS; CANDIDA ALBICANS; FUNGAL GENE; FUNGAL GENOME; FUNGAL STRAIN; FUNGUS ISOLATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INACTIVATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84879538368     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt075     Document Type: Article

References (47)

1. O'Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 2005; 5: 4.
2. Denning DW, O'Driscoll BR, Hogaboam CM et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-26.
3. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20: 156-74.
4. Izumikawa K, Takazono T, Kohno S. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance. Curr Opin Infect Dis 2010; 23: 584-9.
5. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36: 1-53.
6. Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-76.
7. Ferreira ME, Colombo AL, Paulsen I, et al. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol 2005; 43 Suppl 1: S313-9.
8. Kontoyiannis DP, Sagar N, Hirschi KD. Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother 1999; 43: 2798-800.
9. Lamping E, Monk BC, Niimi K, et al. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 2007; 6: 1150-65.
10. Akins RA. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 2005; 43: 285-318.
11. Bennett JE, Izumikawa K, Marr KA. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2004; 48: 1773-7.
12. Brun S, Berges T, Poupard P, et al. Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother 2004; 48: 1788-96.
13. Helmerhorst EJ, Venuleo C, Sanglard D, et al. Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5. Antimicrob Agents Chemother 2006; 50: 1100-3.
14. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73-85.
15. Tsai HF, Krol AA, Sarti KE, et al. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Chemother 2006; 50: 1384-92.
16. White TC, Holleman S, Dy F, et al. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704-13.
17. Cowen LE, Anderson JB, Kohn LM. Evolution of drug resistance in Candida albicans. Annu Rev Microbiol 2002; 56: 139-65.
18. Cowen LE, Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 2008; 7: 747-64.
19. Lupetti A, Danesi R, Campa M, et al. Molecular basis of resistance to azole antifungals. Trends Mol Med 2002; 8: 76-81.
20. Marichal P, Koymans L, Willemsens S, et al. Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 2701-13.
21. Sanglard D, Ischer F, Calabrese D, et al. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Resist Updat 1998; 1: 255-65.
22. Selmecki A, Forche A, Berman J. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 2006; 313: 367-70.
23. Selmecki A, Gerami-Nejad M, Paulson C, et al. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol 2008; 68: 624-41.
24. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-8.
25. Pfaller MA, Messer SA, Boyken L, et al. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol 2008; 46: 2568-72.
26. Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 2010; 65: 2116-8.
27. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49 Suppl 1: S90-5.
28. Verweij PE, Snelders E, Kema GH, et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?. Lancet Infect Dis 2009; 9: 789-95.
29. Chowdhary A, Kathuria S, Randhawa HS, et al. Isolation of multipletriazole- resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 2012; 67: 362-6.
30. Lockhart SR, Frade JP, Etienne KA, et al. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 2011; 55: 4465-8.
31. DenningDW, Park S, Lass-Florl Cet al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123-9.
32. Tobin MB, Peery RB, Skatrud PL. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. Gene 1997; 200: 11-23.
33. Slaven JW, Anderson MJ, Sanglard D, et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol 2002; 36: 199-206.
34. Nascimento AM, Goldman GH, Park S, et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance toitraconazole.AntimicrobAgents Chemother2003;47: 1719-26.
35. Rajendran R, Mowat E, McCulloch E, et al. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 2011; 55: 2092-7.
36. da Silva FerreiraME, Malavazi I, SavoldiM, et al. Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole. Curr Genet 2006; 50: 32-44.
37. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidiaforming moulds. Clin Microbiol Infect 2008; 14: 982-4.
38. Vogel HJ. A convenient growth medium for Neurospora (Medium N). Microbiol Gen Bull 1956; 13: 42-3.
39. Fraczek MG, Rashid R, Denson M, et al. Aspergillus fumigatus allergen expression is coordinately regulated in response to hydrogen peroxide and cyclic AMP. Clin Mol Allergy 2010; 3: 8-15.
40. Yuan JS, Burris J, Stewart NR, et al. Statistical tools for transgene copy number estimation based on real-time PCR. BMC Bioinformatics 2007; 8 Suppl 7: S6.
41. Yang L, Ukil L, Osmani A, et al. Rapid production of gene replacement constructs and generation of a green fluorescent protein-tagged centromeric marker in Aspergillus nidulans. Eukaryot Cell 2004; 3: 1359-62.
42. Szewczyk E, Nayak T, Oakley CE, et al. Fusion PCR and gene targeting in Aspergillus nidulans. Nat Protoc 2006; 1: 3111-20.
43. Punt PJ, Oliver RP, Dingemanse MA, et al. Transformation of Aspergillus based on the hygromycin B resistance marker from Escherichia coli. Gene 1987; 56: 117-24.
44. Weidner G, d'Enfert C, Koch A, et al. Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine 5'-monophosphate decarboxylase. Curr Genet 1998; 33: 378-85.
45. Mattern IE, Punt PJ. A vector of Aspergillus transformation conferring phleomycin resistance. Fungal Genet Newsl 1988; 55: 25.
46. Ballance DJ, Turner G. Development of a high-frequency transforming vector for Aspergillus nidulans. Gene 1985; 36: 321-31.
47. Bowyer P, Mosquera J, Anderson M, et al. Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus. FEMS Microbiol Lett 2012; 332: 10-9.